These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33517565)

  • 21. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does surfactant nebulization prevent early intubation in preterm infants? A protocol for a systematic review and meta-analysis.
    Gaertner VD; Bassler D; Rüegger CM
    Syst Rev; 2021 Jan; 10(1):9. PubMed ID: 33407775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.
    Sankar MJ; Gupta N; Jain K; Agarwal R; Paul VK
    J Perinatol; 2016 May; 36 Suppl 1(Suppl 1):S36-48. PubMed ID: 27109091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation.
    Qureshi MJ; Kumar M
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD003314. PubMed ID: 29542112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supraglottic airway devices for surfactant treatment: systematic review and meta-analysis.
    Calevo MG; Veronese N; Cavallin F; Paola C; Micaglio M; Trevisanuto D
    J Perinatol; 2019 Feb; 39(2):173-183. PubMed ID: 30518796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic surfactant for respiratory distress syndrome in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001149. PubMed ID: 10796417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial.
    Attridge JT; Stewart C; Stukenborg GJ; Kattwinkel J
    Am J Perinatol; 2013 Mar; 30(3):201-6. PubMed ID: 22893557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
    More K; Sakhuja P; Shah PS
    JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late surfactant administration after 48 hours of age in preterm neonates with respiratory insufficiency: a systematic review and meta-analysis.
    Solís-García G; Elias S; Dunn M; Jasani B
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):301-307. PubMed ID: 38071552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Sivakaanthan A; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002975. PubMed ID: 33058139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Less Invasive Surfactant Administration: A Viewpoint.
    Mani S; Rawat M
    Am J Perinatol; 2024 Jan; 41(2):211-227. PubMed ID: 36539205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008310. PubMed ID: 23076945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adult patients.
    Strametz R; Pachler C; Kramer JF; Byhahn C; Siebenhofer A; Weberschock T
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009901. PubMed ID: 24979320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome.
    Trevisanuto D; Grazzina N; Ferrarese P; Micaglio M; Verghese C; Zanardo V
    Biol Neonate; 2005; 87(4):217-20. PubMed ID: 15650304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.